Tyra Biosciences (TYRA) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.47
- EPS estimate
- −$0.53
- EPS surprise
- +11.22%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 14, 2025
The latest quarter in Tyra Biosciences' table is Q2 2025, reported on August 14, 2025. Tyra posted a loss of $0.47 per share, narrower than the estimated $0.53 loss, a beat of 11.22%. The table shows no revenue for this or any other quarter. Compared with Q2 2024, the loss widened from $0.32 per share.
Tyra posted a loss in all 16 quarters in the table, which starts in Q3 2021. Annual losses per share grew from $1.33 in 2022 to $1.61 in 2023, then eased to $1.51 in 2024. The first half of 2025 adds up to a $0.94 loss, against $0.67 a year earlier. The largest quarterly loss was $0.72, in Q3 2021, and the smallest was $0.24, in Q4 2021. Since 2022, quarterly losses have ranged from $0.28 to $0.53 per share. Tyra's result was better than the estimate in nine of the 16 quarters, including the last three.
The table shows no quarter after Q2 2025. Tyra reported Q3 results between November 3 and November 7 in each year from 2021 to 2024. The next row added here will show how the quarterly loss compares with the $0.47 of Q1 and Q2 2025.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 14, 2025 | −$0.53 | −$0.47 | +11.22% | $0.00 | SEC |
| Q1 2025 | May 8, 2025 | −$0.49 | −$0.47 | +3.25% | $0.00 | SEC |
| Q4 2024 | Mar 27, 2025 | −$0.47 | −$0.43 | +9.24% | $0.00 | SEC |
| Q3 2024 | Nov 7, 2024 | −$0.40 | −$0.41 | −2.81% | $0.00 | SEC |
| Q2 2024 | Aug 7, 2024 | −$0.41 | −$0.32 | +21.65% | $0.00 | SEC |
| Q1 2024 | May 9, 2024 | −$0.46 | −$0.35 | +23.08% | $0.00 | SEC |
| Q4 2023 | Mar 19, 2024 | −$0.48 | −$0.53 | −10.42% | $0.00 | SEC |
| Q3 2023 | Nov 7, 2023 | −$0.35 | −$0.49 | −38.69% | $0.00 | SEC |
| Q2 2023 | Aug 10, 2023 | −$0.34 | −$0.31 | +8.37% | $0.00 | SEC |
| Q1 2023 | May 4, 2023 | −$0.37 | −$0.28 | +23.50% | $0.00 | SEC |
| Q4 2022 | Mar 22, 2023 | −$0.36 | −$0.31 | +13.89% | $0.00 | SEC |
| Q3 2022 | Nov 3, 2022 | −$0.41 | −$0.30 | +26.38% | $0.00 | SEC |
| Q2 2022 | Aug 4, 2022 | −$0.32 | −$0.36 | −12.50% | $0.00 | SEC |
| Q1 2022 | May 5, 2022 | −$0.28 | −$0.36 | −28.57% | $0.00 | SEC |
| Q4 2021 | Mar 3, 2022 | −$0.21 | −$0.24 | −14.29% | $0.00 | SEC |
| Q3 2021 | Nov 3, 2021 | −$0.39 | −$0.72 | −83.07% | $0.00 | SEC |
Quarterly revenue
Frequently asked questions
When did Tyra Biosciences (TYRA) last report earnings?
Tyra Biosciences last reported on Aug 14, 2025, covering fiscal Q2 2025.
Did TYRA beat earnings estimates?
Yes. Tyra Biosciences reported EPS of −$0.47 for Q2 2025 against a −$0.53 estimate — a 11.22% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.